October 7, 2014
A US jury ordered Takeda Pharmaceutical to pay US$2.05 million in compensatory damages in a Philadelphia product liability case involving the company’s type 2 diabetes drug Actos (pioglitazone). The leading Japanese drug maker is set to challenge the verdict, saying...read more